Antiviral Efficacy of Pralatrexate against SARS-CoV-2

被引：9
|
作者：
Bae, Joon-Yong [1 ]
Lee, Gee Eun [1 ]
Park, Heedo [1 ]
Cho, Juyoung [1 ]
Kim, Jeonghun [1 ]
Lee, Jungmin [1 ]
Kim, Kisoon [1 ]
Kim, Jin Il [1 ,2 ]
Park, Man-Seong [1 ,2 ]
机构：
[1] Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South Korea
[2] Korea Univ, Biosafety Ctr, Coll Med, Seoul 02841, South Korea
来源：
BIOMOLECULES & THERAPEUTICS | 2021年 / 29卷 / 03期
基金：
新加坡国家研究基金会;
关键词：
Antiviral; COVID-19; Drug repurposing; SARS-CoV-2;
D O I：
10.4062/biomolther.2021.032
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Novel coronavirus (SARS-CoV-2) has caused more than 100 million confirmed cases of human infectious disease (COVID-19) since December 2019 to paralyze our global community. However, only limited access has been allowed to COVID-19 vaccines and antiviral treatment options. Here, we report the efficacy of the anticancer drug pralatrexate against SARS-CoV-2. In Vero and human lung epithelial Calu-3 cells, pralatrexate reduced viral RNA copies of SARS-CoV-2 without detectable cytotoxicity, and viral replication was successfully inhibited in a dose-dependent manner. In a time-to-addition assay, pralatrexate treatment at almost half a day after infection also exhibited inhibitory effects on the replication of SARS-CoV-2 in Calu-3 cells. Taken together, these results suggest the potential of pralatrexate as a drug repurposing COVID-19 remedy.
引用
收藏
页码：268 / 272
页数：5
相关论文
共 50 条
  • [41] 5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
    Mya Myat Ngwe Tun
    Takaya Sakura
    Yasuteru Sakurai
    Yohei Kurosaki
    Daniel Ken Inaoka
    Norifumi Shioda
    Chris Smith
    Jiro Yasuda
    Kouichi Morita
    Kiyoshi Kita
    Tropical Medicine and Health, 50
  • [42] Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
    Romain Marlin
    Delphine Desjardins
    Vanessa Contreras
    Guillaume Lingas
    Caroline Solas
    Pierre Roques
    Thibaut Naninck
    Quentin Pascal
    Sylvie Behillil
    Pauline Maisonnasse
    Julien Lemaitre
    Nidhal Kahlaoui
    Benoit Delache
    Andrés Pizzorno
    Antoine Nougairede
    Camille Ludot
    Olivier Terrier
    Nathalie Dereuddre-Bosquet
    Francis Relouzat
    Catherine Chapon
    Raphael Ho Tsong Fang
    Sylvie van der Werf
    Manuel Rosa Calatrava
    Denis Malvy
    Xavier de Lamballerie
    Jeremie Guedj
    Roger Le Grand
    Nature Communications, 13
  • [43] 5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
    Ngwe Tun, Mya Myat
    Sakura, Takaya
    Sakurai, Yasuteru
    Kurosaki, Yohei
    Inaoka, Daniel Ken
    Shioda, Norifumi
    Smith, Chris
    Yasuda, Jiro
    Morita, Kouichi
    Kita, Kiyoshi
    TROPICAL MEDICINE AND HEALTH, 2022, 50 (01)
  • [44] Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
    Marlin, Romain
    Desjardins, Delphine
    Contreras, Vanessa
    Lingas, Guillaume
    Solas, Caroline
    Roques, Pierre
    Naninck, Thibaut
    Pascal, Quentin
    Behillil, Sylvie
    Maisonnasse, Pauline
    Lemaitre, Julien
    Kahlaoui, Nidhal
    Delache, Benoit
    Pizzorno, Andres
    Nougairede, Antoine
    Ludot, Camille
    Terrier, Olivier
    Dereuddre-Bosquet, Nathalie
    Relouzat, Francis
    Chapon, Catherine
    Fang, Raphael Ho Tsong
    van der Werf, Sylvie
    Calatrava, Manuel Rosa
    Malvy, Denis
    de Lamballerie, Xavier
    Guedj, Jeremie
    Le Grand, Roger
    NATURE COMMUNICATIONS, 2022, 13 (01) : 5108
  • [45] An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection
    Luigi Rosa
    Antimo Cutone
    Maria Pia Conte
    Elena Campione
    Luca Bianchi
    Piera Valenti
    BioMetals, 2023, 36 : 417 - 436
  • [46] In vitro efficacy of Artemisia extracts against SARS-CoV-2
    Nie, Chuanxiong
    Trimpert, Jakob
    Moon, Sooyeon
    Haag, Rainer
    Gilmore, Kerry
    Kaufer, Benedikt B.
    Seeberger, Peter H.
    VIROLOGY JOURNAL, 2021, 18 (01)
  • [47] In vitro efficacy of Artemisia extracts against SARS-CoV-2
    Chuanxiong Nie
    Jakob Trimpert
    Sooyeon Moon
    Rainer Haag
    Kerry Gilmore
    Benedikt B. Kaufer
    Peter H. Seeberger
    Virology Journal, 18
  • [48] Microbicidal actives with virucidal efficacy against SARS-CoV-2
    Ijaz, M. Khalid
    Whitehead, Kelly
    Srinivasan, Vanita
    McKinney, Julie
    Rubino, Joseph R.
    Ripley, Mark
    Jones, Chris
    Nims, Raymond W.
    Charlesworth, Bruce
    AMERICAN JOURNAL OF INFECTION CONTROL, 2020, 48 (08) : 972 - 973
  • [49] Residual antimicrobial coating efficacy against SARS-CoV-2
    Hardison, Rachael L.
    Ryan, Shawn P.
    Limmer, Rebecca A.
    Crouse, Margaret
    Nelson, Sarah W.
    Barriga, Daniela
    Ghere, Jessica M.
    Stewart, Michael J.
    Lee, Sang Don
    Taylor, Brian M.
    James, Ryan R.
    Calfee, Michael W.
    Howard, Megan W.
    JOURNAL OF APPLIED MICROBIOLOGY, 2022, 132 (04) : 3375 - 3386
  • [50] Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients
    Arends, Eline J.
    Meziyerh, Soufian
    Moes, Dirk Jan A. R.
    Kamerling, Sylvia W. A.
    van der Kooy, Sandra
    Ogando, Natacha S.
    Snijder, Eric J.
    van Hemert, Martijn
    Visser, Leo G.
    Feltkamp, Mariet C. W.
    Claas, Eric C. J.
    Rabelink, Ton J.
    van Kooten, Cees
    de Vries, Aiko P. J.
    Teng, Y. K. Onno
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (12): : 2654 - 2664
12345